FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/11/021967 [Registered on: 11/11/2019] Trial Registered Prospectively
Last Modified On: 17/12/2019
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   assessment of Quality of life (QOL) in colorectal cancer patients with colostomy 
Scientific Title of Study   A prospective study to assess the Quality of life (QOL) in colorectal cancer patients with colostomy 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DIVYA KHOSLA  
Designation  ASSISTANT PROFESSOR 
Affiliation  PGIMER , CHANDIGARH 
Address  DEPARTMENT OF RADIOTHERAPY AND ONCOLOGY , PGIMER SECTOR 12 CHANDIGARH

Chandigarh
CHANDIGARH
160012
India 
Phone  9877638478  
Fax    
Email  dr_divya_khosla@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  DIVYA KHOSLA  
Designation  ASSISTANT PROFESSOR 
Affiliation  PGIMER , CHANDIGARH 
Address  DEPARTMENT OF RADIOTHERAPY AND ONCOLOGY , PGIMER SECTOR 12 CHANDIGARH

Chandigarh
CHANDIGARH
160012
India 
Phone  9877638478  
Fax    
Email  dr_divya_khosla@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DIVYA KHOSLA  
Designation  ASSISTANT PROFESSOR 
Affiliation  PGIMER , CHANDIGARH 
Address  DEPARTMENT OF RADIOTHERAPY AND ONCOLOGY , PGIMER SECTOR 12 CHANDIGARH

Chandigarh
CHANDIGARH
160012
India 
Phone  9877638478  
Fax    
Email  dr_divya_khosla@yahoo.com  
 
Source of Monetary or Material Support  
PGIMER CHANDIGARH 
 
Primary Sponsor  
Name  PGIMER CHANDIGARH 
Address  DEPARTMENT OF RADIOTHERAPY AND ONCOLOGY , PGIMER SECTOR 12 CHANDIGARH 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR DIVYA KHOSLA  PGIMER CHANDIGARH  pgimer sector 12
Chandigarh
CHANDIGARH 
09117227475

dr_divya_khosla@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE, PGIMER CHANDIGARH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C189||Malignant neoplasm of colon, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Diagnosis of primary colorectal carcinoma histologically confirmed and treated with radical resection
2. Stoma in situ
3. Consenting for participation and follow up
 
 
ExclusionCriteria 
Details  1. Residual/ recurrent disease at present
2. Wide spread metastatic disease at initial presentation
3. Previous history of malignancy other than colorectal cancer
4. Any other serious illness and or major organ dysfunction
 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
1. To assess the quality of life in patients of colorectal cancer with stoma.
2. To assess the impact of socio-demographic; health-related; cancer-related ,surgical procedures and lifestyle factors on QOL
 
3 MONTH, 6 MONTH AND 12 MONTH 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the impact of socio-demographic; health-related; cancer-related ,surgical procedures and lifestyle factors on QOL
 
3 MONTHS , 6 MONTHS AND 12 MONTHS  
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/11/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Colorectal cancer is the third most commonly diagnosed cancer in males and the second in females, with approximately 1.8 million new cancer cases occurring in 2018 .It ranks third in terms of incidence and second leading in terms of mortality. Colorectal cancer incidence rates are about 3-fold higher in transitioned versus transitioning countries. In India, colorectal cancer is the fourth most common malignancy in males and fifth most common malignancy in females.

Surgery remains the mainstay of curative treatment for colorectal cancers. Despite significant advances in the detection and treatment of colorectal cancers, significant number of patients requires an intestinal stoma. During this procedure, the colon is connected to a hole in the abdomen (called a stoma) to divert stool away from a damaged or surgically repaired part of the colon or rectum. Colostomies may be temporary or permanent depending on the location of tumor and whether it is possible to obtain a safety margin of resection. Some colostomies may be reversed once the repaired tissue heals. Operations with urgent indications such as patients presenting with symptoms of acute abdomen with perforation and peritonitis are often performed in difficult conditions, and therefore the ending of the surgery by intestinal stoma is the safest procedure. A temporary stoma to protect the anastomosis is strongly recommended, particularly in case of a very low colo-anal anastomosis, an anastomosis in the obese male patient, and after neo-adjuvant treatment . The stoma can be closed after 3-6 months, provided anastomosis is complete and leak is not identified by proctoscopy or double contrast imaging.  In case of adjuvant treatment, closure of the stoma is attempted at 4-6 weeks after the end of treatment.

In oncology, QOL has been defined as a personal sense of well-being encompassing a multidimensional perspective that covers the subjective perceptions of the positive and negative aspects of cancer patients’ symptoms. It includes physical, psychological, social, and spiritual dimensions or domains, and also importantly, disease symptoms and side effects of treatment .QOL is affected by many factors in addition to those that are health-related, such as financial status, job satisfaction, and living conditions. When put into a health context as the duration or severity of morbidity accumulates, these factors influence QOL, and are often referred to as health related QOL . It is pertinent to consider patient’s QOL to understand the effect of disease on their day to day living, and the burden of illness on patient and family. This is not always related to the severity of their disease, by laboratory values or imaging, but by how the disease and possibly its treatment are perceived by the patient . There are many psychosocial factors that need to be taken into consideration as well as symptom-related aspects of QOL .

QOL in colorectal cancer patients is associated with multiple factors. QoL in colorectal cancer patients is associated with number of factors. It is important to identify the patient with a higher risk to have a low QoL and then intervene to the modifiable factors in order to improve QOL in CRC patients.  An important consequence of colorectal surgery is stoma. The presence of stoma adversely influences the QOL as compared to patients undergoing a sphincter-saving surgery . However, various studies did not find a significant difference between the two .

Aims and Objectives

1.     To assess the quality of life in patients of colorectal cancer with stoma.

2.     To assess the impact of socio-demographic; health-related; cancer-related ,surgical procedures and  lifestyle factors on QOL

Detailed research methodology:

Study setting:  Department of Radiotherapy & Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh

Definition of population:

Histologically proven colorectal cancer patients with stoma

Study design:

Prospective hospital-based study

Inclusion criteria:

1.     Diagnosis of primary colorectal carcinoma histologically confirmed and treated with radical resection

2.     Stoma in situ

3.     Consenting for participation and follow up

Exclusion criteria:

1.     Residual/ recurrent disease at present

2.     Wide spread metastatic disease at initial presentation

3.     Previous history of malignancy other than colorectal cancer

4.     Any other serious illness and or major organ dysfunction

Sample size:100 patients

Parameters & procedures:

Assessment

Detailed history

Surgical details

Assessment of QOL at 3 months, 6 months and 1 yearpost surgery by modules

a)     City of Hope QOL questionnaire for a patient with an ostomy

b)    EORTC QLQ-CR 29

c)     EORTC QLQ-C30

Procedures:

All registered Colorectal cancer patients with stoma will be contacted during their visits to the Radiotherapy department and asked about whether if they are interested in participating in the study or not. Subjects who will express interest will be given a copy of consent form along with quality of life questionnaires.  The QOL will be assessed 3 months, 6 months and 1 year post surgery. Patient related, disease related and treatment related parameters will be noted as mentioned below:

Measures:

1. Socio-demographic data: patient’s age, educational status, occupation status, age at diagnosis, marital status, andhousehold income at the time of diagnosis and at interview.

2. Lifestyle factors – physical activity, obesity, dietary intake, smoking, alcohol intake.

2. Type of surgery -abdominoperineal resection (APR), Hartmann’s procedure or coloanal anastomosis (CAA), planned or unplanned surgery

3.Neoadjuvant treatment -chemoradiation or chemotherapy before surgery; number of cycles of chemotherapy, specific chemotherapy drugs used.

4. Tumor related factors -tumor, node, metastasis (TNM) stage; site of tumor(distance from the anal verge to the inferior margin); andcomplications and stoma

5. City of Hope questionnaire - has two components. The first component comprises of 47 forced-choice andopen ended items that relate to patient socio-demographic characteristics as well as work-relateditems, health insurance, sexual activity, psychological support, clothing, diet, and daily ostomycare. The second component contains 43 QOL items using 10-point scales. These QOL itemsare divided into the four domains or subscales- physical, psychological, social and spiritual well being. These QOL items are followed by a statement asking the patient to share a story about livingwith an ostomy, and include the great challenges encountered in having an ostomy.

6. QOL CR-29–EORTC colorectal cancer module consists of four scales and 19 individual items

7. QLQ-C30 – composed of 30 items distributed among 6 functional scales (physical, role, emotional, cognitive and social functions); 3 symptom scales (fatigue, pain, nausea/vomiting)and 6 single items (dyspnea, sleep disturbance, appetite loss, diarrhea, constipation and financial impact).


 
Close